Bin Du
Impact in
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
-
- Antibiotic Use and Resistance
Papers in
- Epidemiology 17
- Sepsis Diagnosis and Treatment 13
-
- Acute Kidney Injury Research 4
- Co-authors
- Jiaqi Pan (5 shared papers)Dechang Chen (4 shared papers)Penglin Ma (2 shared papers)Robin Isaacs (2 shared papers)David Altarac (2 shared papers)Dongxu Sun (2 shared papers)Rui Paulo Moreno (1 shared paper)Sean M. Bagshaw (1 shared paper)
- Journals
- Critical Care Medicine (2 papers)BMC Infectious Diseases (2 papers)Intensive Care Medicine (2 papers)JAMA Network Open (2 papers)The Lancet (1 paper)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Bin Du
26 papers receiving 689 citations
Bin Du's Hit Papers
Peers
Comparison fields: 5 of 69
- Molecular Medicine 192
- Applied Microbiology and Biotechnology 29
- Geriatrics and Gerontology 41
- Critical Care and Intensive Care Medicine 37
- Epidemiology 222
Countries citing papers authored by Bin Du
This map shows the geographic impact of Bin Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bin Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bin Du more than expected).
Fields of papers citing papers by Bin Du
This network shows the impact of papers produced by Bin Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bin Du. The network helps show where Bin Du may publish in the future.
Co-authors
The 25 scholars most cited alongside Bin Du, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Efficacy and safety of sulbactam–durlobactam versus colistin for the treatment of patients with serious infections caused by Acinetobacter baumannii–calcoaceticus complex: a multicentre, randomised, active-controlled, phase 3, non-inferiority clinical trial (ATTACK) Hit paper breakdown → | 2023 | 225 |
| 2 | 2017 | 203 | |
| 3 | 2002 | 81 | |
| 4 | 2005 | 45 | |
| 5 | 2005 | 22 | |
| 6 | 2022 | 15 | |
| 7 | 2025 | 15 | |
| 8 | Right ventricular function of patients with septic shock: clinical significance. | 2000 | 13 |
| 9 | 2022 | 13 | |
| 10 | 2025 | 13 | |
| 11 | 2019 | 12 | |
| 12 | 2022 | 11 | |
| 13 | 2013 | 10 | |
| 14 | 2023 | 8 | |
| 15 | 2006 | 6 | |
| 16 | 2018 | 6 | |
| 17 | 2017 | 4 | |
| 18 | [Genomic polymorphism within interleukin-1 family cytokines influences the outcome of septic patients]. | 2002 | 3 |
| 19 | 2020 | 3 | |
| 20 | 2022 | 3 |
About Bin Du
Bin Du is a scholar working on Epidemiology, Nephrology, Molecular Medicine, Immunology and Hematology, having authored 32 papers that have together received 720 indexed citations. Recurring topics across this work include Sepsis Diagnosis and Treatment (13 papers), Acute Kidney Injury Research (4 papers), Antibiotic Resistance in Bacteria (3 papers), Hemodynamic Monitoring and Therapy (2 papers), Heat shock proteins research (2 papers), Innovations in Medical Education (2 papers), Complement system in diseases (2 papers) and Immune Response and Inflammation (2 papers). The work is most often cited by research in Molecular Medicine (192 citations), Applied Microbiology and Biotechnology (29 citations), Geriatrics and Gerontology (41 citations), Critical Care and Intensive Care Medicine (37 citations) and Epidemiology (222 citations). Bin Du has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Jiaqi Pan, Dechang Chen, Penglin Ma, Robin Isaacs, David Altarac, Dongxu Sun, Rui Paulo Moreno, Sean M. Bagshaw, Gavin Matthew Joynt and Dylan W. de Lange. Their work appears in journals such as Critical Care Medicine, BMC Infectious Diseases, Intensive Care Medicine, JAMA Network Open and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.